Evidence map›Paper›PMID 30898009›Full record

ArticleAutophagy2019

Reduced autophagy efficiency induces innate immune activation leading to neurodegeneration.

Arvind K Shukla, Edward Giniger

Open access · bronzeAbstract readComment
In one paragraph

Article in Autophagy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arvind K Shuklaa National Institute of Neurological Disorders and Stroke , National Institutes of Health , Bethesda , Maryland , USA.
Edward Ginigera National Institute of Neurological Disorders and Stroke , National Institutes of Health , Bethesda , Maryland , USA.ORCID 0000-0002-8340-6158
National Institutes of Health · US

Funding

Roles of Cdk5 in neurodevelopment and neurodegenerationZIANS003106 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GINIGER, EDWARD · 2009 to 2025
$17.0M
6 · The paper itself

Abstract

Macroautophagy/autophagy and innate immunity are central processes in neurodegeneration, but it has been unclear whether they work independently or in combination to assault the neuron. We recently demonstrated that reduced efficiency of autophagy causes hyperactivation of innate immunity, which in turn is necessary and sufficient for loss of dopaminergic neurons in a Cdk5-mediated model of degeneration in Drosophila. Genetically restoring autophagy, or reducing innate immune activation, rescues the dopaminergic neuron loss that occurs due to altered Cdk5 activity. This work revealed an alliance of innate immunity and autophagy that causes neuron loss in Cdk5-mediated neurodegeneration.

Indexed as

AutophagyDrosophila ProteinsAnimalsCyclin-Dependent Kinase 5Dopaminergic NeuronsImmunity, InnateNerve DegenerationCyclin-Dependent Kinase 5Drosophila ProteinsAnti-microbial peptideCdk5; p35innate immunityneurodegeneration

Identifiers

PMID30898009
PMCPMC6526832
OpenAlexW2923314947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.